Selected antimicrobial agents: mechanisms of action, side effects and drug interactions.
Walker
C B
CB
Periodontal Disease Research Center, University of Florida, Gainesville, USA.
D000617:Aminoglycosides / Q000737:chemistry / Q000494:pharmacology; D000900:Anti-Bacterial Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology*; D000890:Anti-Infective Agents / Q000009:adverse effects / Q000737:chemistry / Q000494:pharmacology; D002463:Cell Membrane Permeability / Q000187:drug effects*; D017358:Cell Wall Skeleton / Q000096:biosynthesis / Q000187:drug effects*; D002511:Cephalosporins / Q000737:chemistry / Q000494:pharmacology; D002981:Clindamycin / Q000737:chemistry / Q000494:pharmacology; D004347:Drug Interactions; D006801:Humans; D018942:Macrolides; D009593:Nitroimidazoles / Q000494:pharmacology; D019384:Nucleic Acid Synthesis Inhibitors / Q000009:adverse effects / Q000737:chemistry*; D010406:Penicillins / Q000737:chemistry / Q000494:pharmacology; D015363:Quinolones / Q000494:pharmacology; D012294:Rifamycins / Q000494:pharmacology; D013754:Tetracyclines / Q000737:chemistry / Q000494:pharmacology
D000617:Aminoglycosides; D000900:Anti-Bacterial Agents; D000890:Anti-Infective Agents; D017358:Cell Wall Skeleton; D002511:Cephalosporins; D018942:Macrolides; D009593:Nitroimidazoles; D019384:Nucleic Acid Synthesis Inhibitors; D010406:Penicillins; D015363:Quinolones; D012294:Rifamycins; D013754:Tetracyclines; D002981:Clindamycin